Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dave Gore's Trades That Make Sense -- Ignore unavailable to you. Want to Upgrade?

To: John J. O`Reilly who wrote (16051)	3/19/2003 2:54:42 PM
From: Connor26	Read Replies (1) \| Respond to of 16631

RZYM - there is a lot going on with this stock...... March 10 /PRNewswire-FirstCall/ -- Ribozyme Pharmaceuticals, Inc. (RPI) (Nasdaq: RZYM - News) announced today that a special meeting of stockholders will be held on April 16, 2003. RPI stockholders will be asked to approve the previously announced proposed sale of $48 million in common stock and warrants to purchase common stock to the Sprout Group, Venrock Associates, Oxford Bioscience Partners, Techno Venture Management and Granite Global Ventures. RPI stockholders will also be asked to approve a number of other matters, including a reverse stock split, a name change, and an increase in shares authorized for option issuances and employee benefit programs.